Literature DB >> 22924471

Incident diabetes and statins: the blemish of an undisputed heavy weight champion?

Eiman Jahangir1, Sergio Fazio, Uchechukwu K A Sampson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22924471      PMCID： PMC3612713          DOI： 10.1111/j.1365-2125.2012.04445.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  16 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  J Am Coll Cardiol       Date:  2006-05-16       Impact factor: 24.094

3.  Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Authors:  D J Freeman; J Norrie; N Sattar; R D Neely; S M Cobbe; I Ford; C Isles; A R Lorimer; P W Macfarlane; J H McKillop; C J Packard; J Shepherd; A Gaw
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

4.  Nitric oxide induces apoptosis via Ca2+-dependent processes in the pancreatic beta-cell line MIN6.

Authors:  M Nakata; N Uto; I Maruyama; T Yada
Journal:  Cell Struct Funct       Date:  1999-12       Impact factor: 2.212

5.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

6.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

Review 7.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

8.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

9.  Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.

Authors:  William L Baker; Ripple Talati; C Michael White; Craig I Coleman
Journal:  Diabetes Res Clin Pract       Date:  2009-11-12       Impact factor: 5.602

10.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Authors:  P M Kearney; L Blackwell; R Collins; A Keech; J Simes; R Peto; J Armitage; C Baigent
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321
View more
  2 in total

Review 1.  Stem cell therapy for chronic heart failure: an updated appraisal.

Authors:  Simon Maltais; Steven J Joggerst; Antonis Hatzopoulos; Thomas G DiSalvo; David Zhao; Hak-Joon Sung; Xintong Wang; John G Byrne; Allen J Naftilan
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

Review 2.  Endothelial dysfunction: a unifying hypothesis for the burden of cardiovascular diseases in sub-Saharan Africa.

Authors:  Uchechukwu K A Sampson; Michael M Engelgau; Emmanuel K Peprah; George A Mensah
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.